Market Cap
A$753.8 Million
AUD as of March 1, 2022
US$550.2 Million
| Company | Market Cap (USD) |
|---|---|
McKesson Corporation
|
$88.11 B |
Cencora, Inc.
|
$56.44 B |
Cardinal Health, Inc.
|
$38.66 B |
Henry Schein, Inc.
|
$9.31 B |
Shanghai Pharmaceuticals Holding Co. Ltd
|
$8.37 B |
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$699.59 B |
Johnson & Johnson
|
$374.29 B |
AbbVie
|
$336.94 B |
Novo Nordisk
|
$309.91 B |
UnitedHealth Group
|
$279.90 B |
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Australia
languages
Healthcare
languages
Medical Distribution
Australia Healthcare
Australia Medical Distribution
Australian Pharmaceutical Industries Limited has the following listings and related stock indices.
Stock: ASX: API
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.